CTRI/2023/11/060338尚未招募4 期
Evaluating the effects of Treatment Related Risk Factors on Orthodontically Induced Root Resorption (OIRR) – A Clinical Trial - Nil
Dr Arun Nagrik0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Cases with dentoalveolar class I Bimaxillary proclination malocclusion
- •2.Normal overjet and overbite
- •3.Upper incisor to NA more than 25 degree
- •4.Otherwise well aligned arches(Little index (Littles index 0-4mm)
- •5.To be Treated with Upper and lower first premolar extractions with conventional intrusion and retraction mechanics
排除标准
- •1.Missing permanent first molars
- •2.Peg shaped laterals
- •3.History of trauma
- •4.Dilacerated roots
- •5.Periodontally compromised cases
研究者
相似试验
尚未招募
Unknown
Evaluation of treatment efficacy according to risk group in relapsed childhood acute lymphoblastic leukemiaNeoplasmsKCT0008729Asan Medical Center90
已完成
不适用
To know the outcome of specially prepared blood derivative on treatment of decay of bone due to certain cancer medicines commonly termed as MRONJ (Medicine related osteonecrosis of jaw)CTRI/2017/09/009615no269
已完成
不适用
Comparison of risk and patient-related benefit of treatment with etanercept in elderly patients with rheumatoid arthritisM06.99DRKS00012590Charité - Universitätsmedizin BerlinKlinik mS Rheumatologie und Klinische Immunologie85
招募中
不适用
The evaluation of adverse events and theraputic effects using divided CDDP for advanced urothelial carcinoma patients with Chronic Kidney Disease.rothelial CarcinomaJPRN-UMIN000009202agoya Univerity, Depatment of Urology20
尚未招募
1 期
euroEPO – Type 2 Spinocerebellar Ataxia Phase I-IIType 2 Spinocerebellar AtaxiaRPCEC00000187Center of Molecular Immunology (CIM), CIMAB34